The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Viruses

Topics

Biology

Biochemistry

Chemistry

Medicine

Immunology

Show all topics

DOI

10.3390/v12060629

License

CC-BY

Other Formats

PDF